Skip to Main Content

The U.S. Patent and Trademark Office has removed a senior legal adviser from a high-profile case after she tweeted contentious remarks about the right of AIDS activists to challenge a patent-term extension sought by Gilead Sciences (GILD) for an HIV medicine.

A spokesman for the federal agency told us that Mary Till, a 14-year employee who reviews extension requests, is “no longer working on the matter.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • May one observe that employees of the Executive branch should realize that Twitter can be bad for your career – with one conspicuous exception that comes to mind.

Comments are closed.